ArticleChinese medical journal2019

Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial.

Hong-Yu Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.